Question 1

Am I eligible for this trial based on my current eye condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Netarsudil compare to my current treatment in terms of effectiveness and side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my current medications affect my eligibility for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension clinical trial (NCT02558374). Contact the study team or your healthcare provider for specific answers.

What this study is about